ATYR aTyr Pharma, Inc.
Healthcare$0.48-1.16%ClosedMarket Cap: $47.5M
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$5.13
Target (Median)
$1.25
Target Range
$1.00 - $17.00
Upside from current price: 959.3%
Rating Distribution
2 Strong Buy2 Buy6 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-20 | Freedom Broker | upgrade | Buy | Hold |
| 2025-11-07 | RBC Capital | maintain | Sector Perform | Sector Perform |
| 2025-09-16 | Wells Fargo | downgrade | Equal Weight | Overweight |
| 2025-09-16 | RBC Capital | downgrade | Sector Perform | Outperform |
| 2025-09-15 | LUCID CAPITAL MARKETS | downgrade | Neutral | Buy |
| 2025-09-15 | Cantor Fitzgerald | downgrade | Neutral | Overweight |
| 2025-09-15 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2025-09-15 | Jones Trading | downgrade | Hold | Buy |
| 2025-09-15 | Leerink Partners | downgrade | Market Perform | Outperform |
| 2025-08-22 | Jefferies | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.62 | $8.8M | 6 |
| Sun Dec 31 | $-0.55 | $42.1M | 7 |
| Mon Dec 31 | $-0.36 | $156.0M | 2 |
| Tue Dec 31 | $0.38 | $169.4M | 5 |